Add Company
Join Now

Belite Bio Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Belite Bio's estimated annual revenue is currently $2.8M per year.(i)
  • Belite Bio's estimated revenue per employee is $146,842

Employee Data

  • Belite Bio has 19 Employees.(i)
  • Belite Bio grew their employee count by 27% last year.

Belite Bio's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
Chairman and CEOReveal Email/Phone
3
VP Clinical OperationsReveal Email/Phone
4
Head Regulatory AffairsReveal Email/Phone
5
Senior Director CMCReveal Email/Phone
6
Clinical Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M50%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M4-50%N/AN/A
#6
$0.7M80%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1731%N/AN/A
Add Company

What Is Belite Bio?

Belite Bio Inc is a San Diego based clinical stage biopharmaceutical drug development company targeting untreatable age-related metabolic diseases, including macular degeneration, liver disease and diabetes. Developed from our anti-RBP4 technology platform, our lead candidate, LBS-008, is currently in a Phase I clinical trial for dry age-related macular degeneration and its juvenile form, Stargardt disease. LBS-008 has received Orphan Drug Status in the US and Europe, as well as Rare Pediatric Disease Status in the US.

keywords:N/A

N/A

Total Funding

19

Number of Employees

$2.8M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M19N/AN/A
#2
$1.6M19N/AN/A
#3
$1.2M1927%N/A
#4
$1.7M19-5%N/A
#5
$13.6M19-68%N/A